Founder and CEO of Medlitics, Michael Fasere, speaks about the need to build customised digital healthcare tools for Africa that will address long-term clinical conditions and enable clinicians to depend less on internet connectivity, while carrying out daily clinical routine, writes Emma Okonji What specific gap or personal experience led to the founding of Medlitics, and why did you choose to focus specifically on chronic disease management in Africa, despite the digital infrastructure gap that exist? Medlitics was born from firsthand experience with the fragmentation of healthcare delivery across Africa. We repeatedly saw patients with hypertension, diabetes, cardiovascular disease, and other chronic illnesses move among hospitals, laboratories, pharmacies, and specialists without a unified medical history. Care was episodic rather than continuous, leading to delayed interventions, duplicate tests, avoidable complications, and unnecessary healthcare costs. The challenge isn’t merely access to healthcare—it’s continuity of care. Chronic diseases now account for an increasing share of deaths across Africa, yet most health systems remain designed to treat acute illnesses. Patients often seek care only when complications arise because mechanisms for continuous monitoring, early intervention, and personalized support are limited. We founded Medlitics to shift healthcare from reactive treatment to proactive prevention by integrating Artificial Intelligence (AI), remote monitoring, digital health records, and connected care into a single platform that empowers patients and equips clinicians with better tools to manage long-term conditions. Chronic diseases like hypertension and diabetes are often described as silent killers. How does Medlitics use continuous data tracking to shift patients from reactive crisis management to proactive daily care? Medlitics continuously aggregates health information from multiple sources, including patient-reported outcomes, connected medical devices, laboratory results, medication adherence, lifestyle data, and virtual consultations. Rather than waiting until patients become critically ill, our AI analyzes longitudinal trends to detect subtle signs of deterioration. For example, instead of viewing a single elevated blood pressure reading in isolation, Meddy AI evaluates weeks or months of readings alongside medication adherence, glucose trends, symptoms, BMI, activity levels, and prior clinical history. The platform generates personalized risk scores, early warning alerts, and evidence-based recommendations, enabling both patients and clinicians to intervene earlier. Patients receive daily coaching, medication reminders, educational content, and personalised wellness recommendations, while clinicians receive actionable alerts instead of raw data streams. Our objective is simple: identify deterioration before hospitalisation is necessary. Building digital health tools in Africa comes with infrastructure challenges. How did you design Medlitics technically to work under low-resource conditions? Africa requires healthcare technology designed for African realities rather than imported assumptions. From day one, Medlitics was designed as an offline-first Progressive Web Application (PWA), enabling seamless offline functionality. The architecture enables clinicians and patients to continue working without requiring constant internet connectivity. Data entered offline is securely encrypted, stored locally, and automatically synchronised when connectivity is restored. The additional design principles that we added to our PWA, include: Low-bandwidth optimisation; Mobile-first user experience; Device-independent deployment; Cloud-native microservices; Intelligent synchronisation; Secure local caching; API-first interoperability; and Modular deployment architecture. This allows Medlitics to operate across urban hospitals, rural clinics, community health programmes, and remote regions, even with inconsistent connectivity. How do you balance Artificial Intelligence (AI) insights with physician oversight to ensure safety and trust? At Medlitics, AI augments clinicians, never replacing them. Meddy AI serves as a clinical decision-support system rather than an autonomous diagnostic engine. Every recommendation is accompanied by: Supporting clinical evidence; Risk confidence scoring; Historical trend analysis; Clinical rationale; and Escalation recommendations. High-risk cases are automatically prioritised for review by clinicians. Final diagnoses, treatment decisions, prescriptions, and care plans always remain the responsibility of licensed healthcare professionals. We intentionally designed Meddy AI around a “human-in-the-loop” governance model because trust and accountability
Don't miss out on breaking stories and in-depth articles.
